List of Excipients in API dobutamine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing dobutamine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| HF Acquisition Co LLC DBA HealthFirst | DOBUTAMINE | dobutamine | 51662-1330 | DEXTROSE MONOHYDRATE | |
| HF Acquisition Co LLC DBA HealthFirst | DOBUTAMINE | dobutamine | 51662-1330 | EDETATE DISODIUM | |
| HF Acquisition Co LLC DBA HealthFirst | DOBUTAMINE | dobutamine | 51662-1330 | HYDROCHLORIC ACID | |
| HF Acquisition Co LLC DBA HealthFirst | DOBUTAMINE | dobutamine | 51662-1330 | SODIUM HYDROXIDE | |
| HF Acquisition Co LLC DBA HealthFirst | DOBUTAMINE | dobutamine | 51662-1330 | SODIUM METABISULFITE | |
| HF Acquisition Co LLC DBA HealthFirst | DOBUTAMINE | dobutamine | 51662-1330 | WATER | |
| Baxter Healthcare Corporation | DOBUTAMINE HYDROCHLORIDE IN DEXTROSE | dobutamine hydrochloride | 0338-1073 | DEXTROSE MONOHYDRATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing dobutamine
Detailed excipient profiles for dobutamine
Excipient focus: DEXTROSE MONOHYDRATE
dobutamine drug variants containing DEXTROSE MONOHYDRATE
dobutamine drug variants not containing DEXTROSE MONOHYDRATE
Excipient focus: EDETATE DISODIUM
dobutamine drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co LLC DBA HealthFirst | dobutamine | 51662-1330 |
| Physicians Total Care Inc | dobutamine hydrochloride | 54868-5777 |
| Hospira Inc | dobutamine in dextrose | 0409-2347 |
| >Company | >Ingredient | >NDC |
dobutamine drug variants not containing EDETATE DISODIUM
Excipient focus: HYDROCHLORIC ACID
dobutamine drug variants containing HYDROCHLORIC ACID
dobutamine drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BISULFITE
dobutamine drug variants containing SODIUM BISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | dobutamine hydrochloride | 0338-1073 |
| A-S Medication Solutions | dobutamine hydrochloride | 50090-4562 |
| HF Acquisition Co LLC DBA HealthFirst | dobutamine hydrochloride | 51662-1566 |
| >Company | >Ingredient | >NDC |
dobutamine drug variants not containing SODIUM BISULFITE
Excipient focus: SODIUM HYDROXIDE
dobutamine drug variants containing SODIUM HYDROXIDE
dobutamine drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM METABISULFITE
dobutamine drug variants containing SODIUM METABISULFITE
dobutamine drug variants not containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | dobutamine hydrochloride | 0338-1073 |
| A-S Medication Solutions | dobutamine hydrochloride | 50090-4562 |
| HF Acquisition Co LLC DBA HealthFirst | dobutamine hydrochloride | 51662-1566 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
dobutamine drug variants containing WATER
dobutamine drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | dobutamine | 0409-2344 |
| Hainan Poly Pharm Co Ltd | dobutamine | 14335-171 |
| HF Acquisition Co LLC DBA HealthFirst | dobutamine | 51662-1337 |
| Slate Run Pharmaceuticals | dobutamine | 70436-203 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
